CT Scanner Market: Trends and Opportunities

Factors like growing need for effective and early diagnosis, rising global prevalence of targeted, increasing preference for minimally invasive diagnostic procedures, increasing benefits of CT scans, and technological advancements are driving the growth of the market.

The Global CT Scanner Market is projected to reach USD 6.20 Billion by 2022, at a CAGR of 5.4% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=184364345                

Cone beam CT technology segment poised to grow fastest in CT scanner market.

On the basis of technology, the CT scanners market is segmented into high-slice CT, mid-slice CT, low-slice CT, and cone beam CT technology. The cone beam CT technology segment is expected to grow faster than the other segments during the forecast period, majorly due to factors like procedural advantages; rising market demand for cosmetic dentistry; and ongoing product development & commercialization across major healthcare markets.

Portable CT scanners segment expected to register fastest growth rate in the forecast period.

Based on type, the CT scanners market is divided into stationary and portable CT scanners. Portable CT scanners segment is poised to grow faster than the other segment due to increasing number of device installations across major markets, growing application horizons, and the lower switching costs provided by portable CT scanners.

North America accounted for the largest share of the CT scanner market

Geographically, the CT scanner market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017, which is primarily driven by growth in the aging U.S. population; an increasing public emphasis on minimally invasive & effective disease management strategies; robust reimbursement scenario; increasing adoption of novel applications; and rising public-private investments.

Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=184364345

The major players in the CT scanner market are Koninklijke Philips N.V. (Netherlands), GE Healthcare (U.S.), Toshiba Corporation (Japan), Siemens AG (Germany), Hitachi Ltd. (Japan), Shimadzu Corporation (Japan), Samsung Electronics Co., Ltd. (South Korea), Neusoft Medical Systems Co., Ltd. (China), Medtronic plc (Ireland), Shenzhen Anke High-tech Co., Ltd. (Hong Kong), Accuray Incorporated (U.S.), PlanMED (Finland), Koning Corporation (U.S.), Carestream Health Inc. (U.S.), and PointNix Co. Ltd (South Korea).

 

Stem Cell Therapy Market: Trends and Opportunities

Market growth is driven mainly by factors such as increasing investment in stem cell research and the rising number of GMP-certified stem cell manufacturing plants. However, factors such as ethical concerns and the high cost of stem cell research and manufacturing process likely to hinder the growth of this market.

The global Stem Cell Therapy Market is projected to reach USD 401 million by 2026 from USD 187 million in 2021, at a CAGR of 16.5% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48

Market Segmentation: -

The adipose tissue-derived MSCs segment accounted for the largest share of the cell source segment in the stem cell therapy market in 2020.

Based on the cell source from which stem cells are obtained, the global stem cell therapy market is segmented into four sources. These include adipose tissue-derived MSCs (mesenchymal stem cells), bone marrow-derived MSCs, placenta/umbilical cord-derived MSCs, and other cell sources (which includes human corneal epithelium stem cells, peripheral arterial-derived stem cells, and induced pluripotent stem cell lines). In 2020, adipose tissue-derived MSCs accounted for the markets largest share due to their increasing utilization in treating inflammatory diseases and wounds & injuries. There are several associated advantages, such as ease of harvesting stem cells by minimally invasive methods, simplicity of the isolation procedure, and better quality & proliferation capacity of adipose tissue-derived stem cells.

The musculoskeletal disorders segment accounted for the largest share of the therapeutic application segment in the stem cell therapy  market in 2020

Based on therapeutic application, the global stem cell therapy market is segmented into musculoskeletal disorders, wounds & injuries, cardiovascular diseases, surgeries, inflammatory & autoimmune diseases, neurological disorders, and other therapeutic applications (which include ocular diseases, fat loss, and peripheral arterial diseases). In 2020, the musculoskeletal disorders segment accounted for the largest share of the therapeutic application segment. The large market share of this segment is attributed to the increasing prevalence of musculoskeletal disorders such as osteoarthritis, bone repair, and regeneration.

Regional Analysis: -

The Asia Pacific region is the fastest-growing region of the stem cell therapy market in 2020.

The Asia Pacific region is estimated to grow at the highest CAGR in the stem cell therapy market during the forecast period. Some of the major factors fueling the growth of the APAC market include regulatory approvals and guidelines for product approvals and the presence of major stem cell players in countries such as South Korea, Japan, India, and Australia.

Request for Sample Pages  :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=48

Top Key Players: -

Key players in the stem cell therapy market include Smith & Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), PHARMICELL Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), and NuVasive, Inc. (US).

Which region is lucrative for the blood screening market?

The increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are the key factors driving the growth of this market.

The Blood Screening Market is projected to reach USD 3.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 12.8%.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042

The reagents & kits segment accounted for the largest share of the blood screening market, by product & service, in 2019

Based on product & service, the blood screening market is segmented into reagents and kits, instruments, and software and services. The reagents and kits segment accounted for the largest share of the blood screening market in 2019. The large share of this segment can be attributed to the high consumption and repeated use of reagents & kits in blood screening procedures. Also, the accessibility of a wide range of reagents and the need for reliable, specific, and fast detection of TTIs are driving the growth of the blood screening reagents & kits market.

Blood banks segment to register the highest growth rate during the forecast period

Based on end users, the blood screening market is segmented into blood banks and hospitals. The blood bank segment accounted for the larger market share in 2019 and is projected to witness a higher growth rate during the forecast period. This can be attributed to the increasing demand for donated blood, a growing number of organ transplantation surgeries, rising awareness regarding the safety of blood, an increasing number of donations worldwide, and growth in government funding to charitable trusts.

North America is the largest regional market for blood screening

Based on region, the blood screening market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest market share, followed by Europe. Factors such as the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens, the presence of high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the blood screening market in North America.

Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=267747042  

Top Key Players :-

The prominent players operating in the blood screening market include Grifols (Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US), BioMérieux (France), Bio-Rad Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) ,Ortho Clinical Diagnostics, Inc.(US), Becton, Dickinson and Company (US), DiaSorin (Italy), GFE (Germany), Trinity Biotech (Ireland), Merck Millipore (Germany), GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra & Co. Pvt. Ltd (India).

Lithotripsy Devices Market :Trends and Opportunities

Factors such as the growing incidence of urolithiasis and technological advancements in lithotripsy devices are driving the growth of this market.

The report Lithotripsy Devices Market  is expected to reach USD 1.76 Billion by 2023 from USD 1.41 Billion in 2018, at a CAGR of 4.5%.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=29769904

Market Segmentation:-              

By type, the lithotripsy devices market is classified into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices. In 2017, the extracorporeal shock wave lithotripsy devices segment accounted for the largest share of the market. ESWL is the least invasive of all stone treatments and is considered the treatment modality of choice for a majority of urinary stones.

On the basis of applications, the lithotripsy devices market is categorized into kidney stones, ureteral stones, pancreatic stones, and bile duct stones. In 2017, the kidney stones segment accounted for the largest share of the market. The increasing incidence of kidney stones and the recurrence of these stones over a period of time are the key factors driving the growth of this segment.

On the basis of end user, the lithotripsy devices market is categorized into hospitals, ambulatory surgical centers, and other end users. In 2017, the hospitals segment accounted for the largest share of the global lithotripsy devices market.

Target Audience for this Report:-

• Manufacturers and vendors of lithotripsy devices
• Research associations related to surgeries
• Various research and consulting firms
• Distributors of lithotripsy devices
• Government bodies
• Venture capitalists

Regional Analysis:-

Based on region, the lithotripsy devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America dominated the lithotripsy devices market in 2017. The large share can primarily be attributed to the high prevalence of kidney stones and the large number of surgeries performed each year.

Request for  Sample Pages: -  https://www.marketsandmarkets.com/requestsampleNew.asp?id=29769904  

Top key Players:-

Some of the major players in the lithotripsy devices market are Siemens AG (Germany), Boston Scientific (US), Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and Richard Wolf (Germany).

Needles Market to Witness Steady Growth in the Near Future

Key factors such growing geriatric population, increasing number of hospitals in emerging markets, and high prevalence of chronic diseases are the major factors driving the growth of the needles market across the globe.

The Needles Market is expected to reach USD 8.47 Billion by 2022, at CAGR of 7.8% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223979930

Market Segmentation:-              

On the basis of type, the global needles market is segmented into two broad categories, namely, conventional needles and safety needles. The conventional needles market is estimated to command the larger share of the global needles market in 2017. The growing demand for biosimilar products, the increasing incidence of chronic disease, and the expanding injectables market are the key factors contributing to the growth of this market segment.

Based on product, the market is segmented into suture needles, blood collection needles, ophthalmic needles, dental needles, insufflation needles, pen needles, and other needles.

The needles market is segmented into hypodermic, intravenous, intramuscular, and intraperitoneal needles on the basis of delivery mode. The hypodermic needles segment is expected to account for the largest share of the needles market in 2017.

Key Market Drivers: –
            1 High Prevalence of Chronic Diseases
            2 Growing Geriatric Population
            3 Increasing Number of Hospitals in Emerging Markets
            4 Increasing Demand for Vaccines

Regional Analysis: -

As of 2016, North America held the largest share of the global needles market, followed by Europe. Its dominant share is attributed to the rising incidence of chronic diseases, initiatives by different organizations for the reduction in blood borne infections and increasing prevalence of cardiovascular diseases.

Request for Sample Pages: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=223979930

Top Key Players: -

The key players in the global needles market are Hamilton Company (U.S.), Medtronic plc (Ireland), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), Terumo Corporation (Japan), Novo Nordisk A/s (Denmark), Smiths Medical (U.K.), and Thermo Fisher Scientific (U.S.).

Surgical Robots Market: Trends and Developments

The technological advancements in surgical robots, the increasing adoption of surgical robots, the various advantages of robotic-assisted surgery, and the increase in funding for medical robot research are the key drivers of the surgical robots market. Increasing penetration of surgical robots in ASCs and emerging markets are also supporting the growth of this market.

The Surgical Robots Market  is expected to reach USD 11.8 billion by 2025 from USD 6.7 billion in 2020, at a CAGR of 12.1%.

Ask for PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532

Market Segmentation: -

The surgical robots market is segmented based on product & service into robotic systems, instruments & accessories, and services. The instruments & accessories segment is expected to command the largest share of the market in 2020 and is estimated to grow at the highest CAGR during the forecast period. The recurrent purchase of instruments & accessories as opposed to robotic systems, which are a one-time investment, is the major factor driving the growth of this product segment.

The market is segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications based on applications. The general surgery applications segment is estimated to command the largest share of the market in 2020, and this segment is also projected to register the highest CAGR owing to increased use of surgical robots in general procedures such as bariatric surgery, Heller myotomy, gastrectomy, hernia repair, cholecystectomy, transoral surgery, and pancreatectomy.

Market Drivers: -
1 Advantages of Robotic-Assisted Surgery
2 Technological Advancements
3 Increasing Adoption of Surgical Robots
4 Increase in Funding for Medical Robot Research

Regional Analysis: -

North America is expected to dominate the global surgical robots market in 2020, the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the increasing demand from key markets such as Japan and China and the large patient population in India. Due to this, the availability of robots has also grown in this region.

Request for Sample Pages - https://www.marketsandmarkets.com/requestsampleNew.asp?id=256618532

Top key Players: -

The major players operating in the surgical robots market include Intuitive Surgical (US), Stryker (US), and Medtronic (Ireland).

 

Which of the product segment will dominate the gene expression analysis market in future?

The major factors driving the growth of the gene expression analysis market include decreasing cost of sequencing, rising prevalence of cancer, growing application areas of genomics, and the availability of gene expression databases.

The global Gene Expression Analysis Market is expected to reach USD 4.9 billion by 2023 from USD 3.2 billion in 2018, at a CAGR of 8.8%.

Ask for  PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156613968

Market Segmentation: -

On the basis of products and services, the global gene expression analysis market has been segmented into consumables (reagents, DNA chips), Instruments (PCR, NGS, Microarray, others), and services (gene expression profiling services, bioinformatics solutions). The consumables segment is estimated to command the largest share of the market in 2018 and is also projected to register the highest CAGR. The high growth in this segment can be attributed to the growing decreasing sequencing costs leading to increased adoption of sequencing and other gene expression analysis techniques.

Based on end user, the market has been segmented into pharmaceutical and biotechnology companies, academic institutes and research centers, and other end users. The pharmaceutical and biotechnology companies’ segment is expected to command the largest share of 54.8% of the market in 2018. The large share and high growth of this segment can be attributed to factors such as high volume of research studies involving gene expression analysis and huge capital for high end analysis instruments and consumables.

Regional Analysis: -

Geographically, North America is expected to dominate the global gene expression analysis market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to domestic manufacturing of sequencing systems, western partnerships to improve healthcare, high R&D intensity, government focus on cancer and other life science research, and flourishing bioresearch centers.

Request for  Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=156613968

Top Key Players:-

The major players operating in the gene expression analysis market include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), and Bio-Rad Laboratories, Inc. (US) are the key players in the gene expression analysis market. Other players involved in this market are F. Hoffmann-La Roche Ltd. (Switzerland), GE Healthcare (UK), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies Inc. (US), and QIAGEN N. V. (Netherlands), among others.

Healthcare CRM Market: Trends and Opportunities

 The benefits of CRM software and a growing focus on patient engagement are the major factors driving the growth of the healthcare CRM market.

The report Healthcare CRM Market is projected to reach USD 17.4 billion by 2023 from USD 8.8 billion in 2018, at a CAGR of 14.6% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=88873203

Market Segmentation: -

Based on end user, the healthcare CRM market is segmented into healthcare providers, the life sciences industry, and healthcare payers. The healthcare providers segment is estimated to account for the largest share of the healthcare CRM market in 2018. This segment is also expected to register the highest CAGR during the forecast period. Healthcare providers need to interact with multiple stakeholders, including patients, physicians, other referral healthcare organizations, healthcare payer organizations, pharmaceutical companies, and consumers/potential patients, and each requires unique CRM strategies and solutions. Moreover, there is a growing focus on patient engagement, which is again likely to drive the market for this segment.

On the basis of component, the healthcare CRM market is segmented into software and services. The services segment is expected to dominate the healthcare CRM market in 2018. This segment is also expected to register the highest CAGR during the forecast period. Services form a large component of the healthcare CRM market primarily due to the indispensable role of service providers when it comes to the use of CRM solutions for healthcare. In terms of IT usage and skills, the healthcare industry is still in the nascent stage; it relies heavily on service providers for CRM-related services and support services, such as implementation, integration, training and education, maintenance, and technology upgrades. The recurring need for services such as software upgrades and maintenance is the key factor supporting the growth of this segment.

Regional Analysis: -

Geographically, the global healthcare CRM market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is estimated to hold the largest share of the healthcare CRM market.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=88873203  

Top Key Players: -

The key players in the healthcare CRM market are Salesforce.com, Inc. (US), SAP SE (Germany), Oracle (US), Microsoft (US), IBM (US), Influence Health (US), SugarCRM (US), Accenture (Ireland), Healthgrades (US), and Infor, Inc. (US).

Nerve Repair and Regeneration Market: Trends and Developments

Growth in this market is driven mainly by high incidence of nerve injuries, the growing prevalence of neurological disorders, and rising government support for neurologic disorder research.

The global Nerve Repair and Regeneration Market size is projected to reach USD 9.7 billion by 2025 from USD 6.3 billion in 2020, growing at a CAGR of 9.1% from 2020 to 2025.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883

Market Segmentation: -

By product, the nerve repair market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment is segment is expected to grow at the highest growth rate during the forecast period. The large market share of this segment is driven mainly by rising government expenditure for neurologic disorders, and favorable reimbursement.

Based on the neurostimulation and neuromodulation application, the nerve regeneration market is segmented the neurostimulation and neuromodulation devices market is segmented into internal neurostimulation and neuromodulation applications and external neurostimulation and neuromodulation applications. The internal neurostimulation and neuromodulation segment is estimated to register the highest CAGR during the forecast period.

Based on application, the biomaterials market is segmented into direct nerve repair/neurorrhaphy, nerve grafting, and stem cell therapy. In 2019, the direct nerve repair segment accounted for the largest share of the market.

Recent Developments: -

• In 2020, Medtronic received CE approval for InterStim Micro neurostimulator and InterStim SureScan MRI leads — clearing the technologies for commercial sale and clinical use in Europe
• In 2019, Boston Scientific received FDA approval for the Image Ready MRI for its Vercise Gevia Deep Brain Stimulation System
• In 2020, LivaNova entered into partnership with Verily (US) for evaluation of the effectiveness of Vagus Nerve Stimulation Therapy (VNS Therapy) for difficult-to-treat Depression (DTD)

Regional Analysis: -

The nerve repair market is segmented into five major regions, namely, Europe, North America, the Asia Pacific, Latin America, and Middle East & Africa. In 2019, North America accounted for the largest share of the nerve repair and regeneration industry, followed by Europe.

Request for Sample Pages : - https://www.marketsandmarkets.com/requestsampleNew.asp?id=883 

Top Key Players: -

Some of the major players operating in the global nerve repair market include Medtronic, PLC. (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), AxoGen, Inc. (US), Baxter International, Inc. (US), LivaNova, PLC. (UK), Integra LifeSciences (US), Polyganics (Netherlands), NeuroPace, Inc. (US), Soterix Medical, Inc. (US), Nevro Corp (US), Synapse Biomedical, Inc. (US), Aleva Neurotherapeutics (Switzerland), Collagen Matrix, Inc. (US), KeriMedical (Switzerland), BioWave Corporation (US), NeuroSigma (US), tVNS Technologies GmbH(Germany), and GiMer Medical (Taiwan).

Respiratory Diagnostics Market: Trends and Developments

Major factors driving the market growth are increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in respiratory diagnostic systems. On the other hand, rising healthcare costs and reimbursement concerns are the major factors restraining the growth of the respiratory diagnostics market. High potential emerging markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore offer significant growth opportunities for the key players in the respiratory diagnostics market.

The global Respiratory Diagnostics Market is  projected to reach USD 7.45 Billion by 2021 from USD 5.24 Billion in 2016, at a CAGR of 7.3% from 2016 to 2021.

Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163390459  

The global respiratory diagnostics market is segmented on the basis of product and service, test type, disease, end user, and region.

On the basis of product and service, the respiratory diagnostics market is segmented into instruments and devices, assays and reagents, and software and services. The instruments and devices segment is expected to account for the largest share of the respiratory diagnostics market in 2016.

On the basis of test type, the respiratory diagnostics market is broadly classified into mechanical tests, imaging tests, traditional diagnostic tests, and molecular diagnostic tests. In 2016, the traditional diagnostic tests segment is expected to account for the largest share of the respiratory diagnostics market.

On the basis of disease, the respiratory diagnostics market is segmented into asthma, chronic obstructive pulmonary disease, lung cancer, tuberculosis, and other diseases. The tuberculosis segment is expected to account for the largest share of the respiratory diagnostics market in 2016.

On the basis of end user, the respiratory diagnostics market is categorized into hospital/clinical laboratories, reference laboratories, physician offices, and other end users (including blood banks, point-of-care testing, patient self-testing, home health agencies, nursing homes, and local public health laboratories).

North America is expected to account for the largest share of the global respiratory diagnostics market in 2016, followed by Europe.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=163390459

The respiratory diagnostics market is dominated by established players such as Philips Healthcare (Netherlands), Becton, Dickinson and Company (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Alere, Inc. (U.S.).

Which geographical region is dominating in the veterinary imaging market?

The growth in this market is majorly driven by the growth in the companion animal population, rising demand for pet insurance and growing animal health expenditure, growing number of veterinary practitioners & their rising income levels in developed economies, rising demand for animal-derived food products, and growing prevalence of animal diseases. However, high cost of veterinary imaging instruments and rising pet care costs are expected to restrain the growth of this market.

The report   Veterinary Imaging Market is projected to reach USD 2.2 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 6.7% during the forecast period.  Due to the outbreak of corona svirus globally, there is slight dip in the demand for veterinary imaging systems in first quarter of 2020.

Ask for PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80889726

Market Segmentation: -

Based on product, the veterinary imaging market is segmented into instrument, reagents, and software. The instruments segment accounted for the largest market share in 2019. The large share of this segment can be attributed to the high cost of imaging instruments and the increasing adoption of imaging modalities for disease diagnosis in the treatment of companion animals and livestock.

On the basis of animal type, the veterinary imaging market is segmented into small companion animals, large animals, and other animals. The small companion animal segment accounted for the largest share of the market in 2019. The large share and highest growth of this segment is attributed to the growing pet adoption due to rising urbanization, growing expenditure on pet care, increasing demand for pet insurance, the growing adoption of animal-assisted therapy, economic growth, and the rising incidence of age-related diseases in companion animals.

Based on end users, the veterinary imaging market is segmented into veterinary clinics and diagnostic centers and veterinary hospitals and academic institutions. Veterinary clinics and diagnostic centers accounted for the largest share of the market in 2019. The large share of this segment is attributed to the increasing number of veterinarians and the growing number of private clinical practices across the globe.

Regional Analysis: -

The veterinary imaging market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latina America, and the Middle East and Africa. In 2019, North America accounted for the largest share. The large share of North America can be attributed to the increasing population of companion animals, rising veterinary healthcare expenditure, the growing population of livestock due to the increasing consumption of meat and dairy products, and growth in pet insurance coverage.

Request for Sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=80889726

Top key players: -

Some of the prominent players in this market are GE Healthcare (US), Agfa-Gevaert N.V. (Belgium), Carestream Health, Inc. (US), Esaote S.p.A (Italy), IDEXX Laboratories, Inc. (US), Mindray Medical International Limited (China), Canon Inc. (Japan), Heska Corporation (US), Siemens Healthineers (Germany), FUJIFILM Holdings Corporation (Japan), Konica Minolta (Japan), Samsung Electronics Co. Ltd. (South Korea), E.I. Medical Imaging (US), IMV imaging (UK), SEDECAL (Spain), Clarius Mobile Health (Canada), Shenzhen Ricso Technology Co., Ltd. (China), DRAMIÑSKI S.A. (Poland), EPICA Animal Health (US), and ClearVet Digital Radiography Systems (US).